FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michel Berlan

Research Profile

Physiology

Lipolysis

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Katrien Koppo; Dominique Larrouy; Marie A Marques; Michel Berlan; Magda Bajzova; Jan Polak; Johan Van de Voorde; Jens Bülow; Max Lafontan; François Crampes; Dominique Langin; Vladimir Stich; Isabelle De Glisezinski
Lipid mobilization in subcutaneous adipose tissue during exercise in lean and obese humans. Roles of insulin and natriuretic peptides.
S Wiesner; Andreas L Birkenfeld; Stefan Engeli; S Haufe; L Brechtel; J Wein; M Hermsdorf; B Karnahl; Michel Berlan; Max Lafontan; F C G J Sweep; Friedrich C Luft; Jens Jordan
Neurohumoral and metabolic response to exercise in water.
Fabien Pillard; Virginie Van Wymelbeke; Eric Garrigue; Cédric Moro; François Crampes; Jean-Claude Guilland; Michel Berlan; Isabelle De Glisezinski; Isabelle Harant; Daniel Rivière; Laurent Brondel
Lipid oxidation in overweight men after exercise and food intake.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michel Berlan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Katrien Koppo; Dominique Larrouy; Marie A Marques; Michel Berlan; Magda Bajzova; Jan Polak; Johan Van de Voorde; Jens Bülow; Max Lafontan; François Crampes; Dominique Langin; Vladimir Stich; Isabelle De Glisezinski
Lipid mobilization in subcutaneous adipose tissue during exercise in lean and obese humans. Roles of insulin and natriuretic peptides.
American journal of physiology. Endocrinology and metabolism 2010;299(2):E258-65.
2010: S Wiesner; Andreas L Birkenfeld; Stefan Engeli; S Haufe; L Brechtel; J Wein; M Hermsdorf; B Karnahl; Michel Berlan; Max Lafontan; F C G J Sweep; Friedrich C Luft; Jens Jordan
Neurohumoral and metabolic response to exercise in water.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2010;42(5):334-9.
2010: Fabien Pillard; Virginie Van Wymelbeke; Eric Garrigue; Cédric Moro; François Crampes; Jean-Claude Guilland; Michel Berlan; Isabelle De Glisezinski; Isabelle Harant; Daniel Rivière; Laurent Brondel
Lipid oxidation in overweight men after exercise and food intake.
Metabolism: clinical and experimental 2010;59(2):267-74.
2009: Isabelle De Glisezinski; Dominique Larrouy; Magda Bajzova; K Koppo; Jan Polak; Michel Berlan; J Bulow; Dominique Langin; Marie-Adeline Marques; François Crampes; Max Lafontan; Vladimir Stich
Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.
The Journal of physiology 2009;587(Pt 13):3393-404.
2008: Andreas L Birkenfeld; Petra Budziarek; Michael Boschmann; Cedric Moro; Frauke Adams; Gabriele Franke; Michel Berlan; Marie A Marques; Fred C G J Sweep; Friedrich C Luft; Max Lafontan; Jens Jordan
Atrial natriuretic peptide induces postprandial lipid oxidation in humans.
Diabetes 2008;57(12):3199-204.
2008: Cédric Moro; Fabien Pillard; Isabelle De Glisezinski; Eva Klimcakova; Francois Crampes; Claire Thalamas; Isabelle Harant; Marie-Adeline Marques; Max Lafontan; Michel Berlan
Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men.
American journal of physiology. Endocrinology and metabolism 2008;295(2):E505-13.
2008: Max Lafontan; Cédric Moro; Michel Berlan; François Crampes; Coralie Sengenes; Jean Galitzky
Control of lipolysis by natriuretic peptides and cyclic GMP.
Trends in endocrinology and metabolism: TEM 2008;19(4):130-7.
2007: Cédric Moro; Eva Klimcakova; Max Lafontan; Michel Berlan; Jean Galitzky
Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.
British journal of pharmacology 2007;152(7):1102-10.
2007: Jan Polak; Cédric Moro; David Bessière; Jindra Hejnova; Marie A Marquès; Magda Bajzova; Max Lafontan; François Crampes; Michel Berlan; Vladimir Stich
Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue.
Journal of lipid research 2007;48(10):2236-46.
2007: Fabien Pillard; Cédric Moro; Isabelle Harant; Eric Garrigue; Max Lafontan; Michel Berlan; François Crampes; Isabelle De Glisezinski; Daniel Rivière
Lipid oxidation according to intensity and exercise duration in overweight men and women.
Obesity (Silver Spring, Md.) 2007;15(9):2256-62.
2007: Cédric Moro; Fabien Pillard; Isabelle De Glisezinski; François Crampes; Claire Thalamas; Isabelle Harant; Marie-Adeline Marques; Max Lafontan; Michel Berlan
Sex differences in lipolysis-regulating mechanisms in overweight subjects: effect of exercise intensity.
Obesity (Silver Spring, Md.) 2007;15(9):2245-55.
2007: Cédric Moro; Fabien Pillard; Isabelle De Glisezinski; François Crampes; Claire Thalamas; Isabelle Harant; Marie-Adeline Marques; Max Lafontan; Michel Berlan
Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;293(2):R612-7.
2007: Jan Polak; Cédric Moro; Eva Klimcakova; Michaela Kovacikova; Magda Bajzova; Michaela Vitkova; Z Kovacova; R Sotornik; Michel Berlan; Nathalie Viguerie; Dominique Langin; Vladimir Stich
The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients.
American journal of physiology. Endocrinology and metabolism 2007;293(1):E246-51.
2007: Cédric Moro; Eva Klimcakova; Karine Lolmède; Michel Berlan; Max Lafontan; Vladimir Stich; Anne Bouloumié; Jean Galitzky; Peter Arner; Dominique Langin
Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.
Diabetologia 2007;50(5):1038-47.
2006: Andreas L Birkenfeld; Michael Boschmann; Cedric Moro; Frauke Adams; Karsten Heusser; Jens Tank; André Diedrich; Christoph Schroeder; Gabriele Franke; Michel Berlan; Friedrich C Luft; Max Lafontan; Jens Jordan
Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.
The Journal of clinical endocrinology and metabolism 2006;91(12):5069-75.
2006: Eva Klimcakova; Jan Polak; Cédric Moro; Jindra Hejnova; Marek Majercik; Nathalie Viguerie; Michel Berlan; Dominique Langin; Vladimir Stich
Dynamic strength training improves insulin sensitivity without altering plasma levels and gene expression of adipokines in subcutaneous adipose tissue in obese men.
The Journal of clinical endocrinology and metabolism 2006;91(12):5107-12.
2006: Jan Polak; Eva Klimcakova; Cédric Moro; Nathalie Viguerie; Michel Berlan; Jindra Hejnova; Blanka Richterova; Ivan Kraus; Dominique Langin; Vladimir Stich
Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women.
Metabolism: clinical and experimental 2006;55(10):1375-81.
2006: Cédric Moro; Jan Polak; Jindra Hejnova; Eva Klimcakova; François Crampes; Vladimir Stich; Max Lafontan; Michel Berlan
Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise.
American journal of physiology. Endocrinology and metabolism 2006;290(5):E864-9.
2006: Cédric Moro; Michel Berlan
Cardiovascular and metabolic effects of natriuretic peptides.
Fundamental & clinical pharmacology 2006;20(1):41-9.
2006: Cédric Moro; Michel Berlan; Max Lafontan
[Physiological and pathophysiological features of the control of lipolysis and lipid mobilization by natriuretic peptides].
Journal de la Société de biologie 2006;200(1):67-76.
2005: Coralie Sengenes; Cédric Moro; Jean Galitzky; Michel Berlan; Max Lafontan
[Natriuretic peptides: a new lipolytic pathway in human fat cells].
Médecine sciences : M/S 2005;21 Spec No():29-33.
2005: Jan Polak; Cédric Moro; Eva Klimcakova; Jindra Hejnova; Marek Majercik; Nathalie Viguerie; Dominique Langin; Max Lafontan; Vladimir Stich; Michel Berlan
Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects.
Diabetologia 2005;48(12):2631-40.
2005: Max Lafontan; Cédric Moro; Coralie Sengenes; Jean Galitzky; François Crampes; Michel Berlan
An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2032-42.
2005: Cédric Moro; Fabien Pillard; Isabelle De Glisezinski; Isabelle Harant; Daniel Rivière; Vladimir Stich; Max Lafontan; François Crampes; Michel Berlan
Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men.
Medicine and science in sports and exercise 2005;37(7):1126-32.
2005: Andreas L Birkenfeld; Michael Boschmann; Cedric Moro; Frauke Adams; Karsten Heusser; Gabriele Franke; Michel Berlan; Friedrich C Luft; Max Lafontan; Jens Jordan
Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans.
The Journal of clinical endocrinology and metabolism 2005;90(6):3622-8.
2005: Coralie Sengenes; Cédric Moro; Jean Galitzky; Michel Berlan; Max Lafontan
[Natriuretic peptides: a new lipolytic pathway in human fat cells].
Médecine sciences : M/S 2005;21(1):61-5.
2005: Cédric Moro; Jan Polak; Blanka Richterova; Coralie Sengenes; Terezie Pelikanova; Jean Galitzky; Vladimir Stich; Max Lafontan; Michel Berlan
Differential regulation of atrial natriuretic peptide- and adrenergic receptor-dependent lipolytic pathways in human adipose tissue.
Metabolism: clinical and experimental 2005;54(1):122-31.
2004: Vladimir Stich; Michel Berlan
Physiological regulation of NEFA availability: lipolysis pathway.
The Proceedings of the Nutrition Society 2004;63(2):369-74.
2004: Cédric Moro; François Crampes; Coralie Sengenes; Isabelle De Glisezinski; Jean Galitzky; Claire Thalamas; Max Lafontan; Michel Berlan
Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(7):908-10.
2004: Blanka Richterova; Vladimir Stich; Cédric Moro; Jan Polak; Eva Klimcakova; Marek Majercik; Isabelle Harant; Nathalie Viguerie; François Crampes; Dominique Langin; Max Lafontan; Michel Berlan
Effect of endurance training on adrenergic control of lipolysis in adipose tissue of obese women.
The Journal of clinical endocrinology and metabolism 2004;89(3):1325-31.
2004: Cédric Moro; Jean Galitzky; Coralie Sengenes; François Crampes; Max Lafontan; Michel Berlan
Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
The Journal of pharmacology and experimental therapeutics 2004;308(3):984-92.
2003: Coralie Sengenes; Anne Bouloumie; Hans Hauner; Michel Berlan; Rudi Busse; Max Lafontan; Jean Galitzky
Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.
The Journal of biological chemistry 2003;278(49):48617-26.
2003: Isabelle De Glisezinski; Cédric Moro; Fabien Pillard; Fabrice Marion-Latard; Isabelle Harant; M Meste; Michel Berlan; François Crampes; Daniel Rivière
Aerobic training improves exercise-induced lipolysis in SCAT and lipid utilization in overweight men.
American journal of physiology. Endocrinology and metabolism 2003;285(5):E984-90.
2003: Vladimir Stich; Terezie Pelikanova; Petr Wohl; Coralie Sengenes; Alexia Zakaroff-Girard; Max Lafontan; Michel Berlan
Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men.
American journal of physiology. Endocrinology and metabolism 2003;285(3):E599-607.
2003: Max Lafontan; Michel Berlan
Do regional differences in adipocyte biology provide new pathophysiological insights?
Trends in pharmacological sciences 2003;24(6):276-83.
2003: Stephane Gesta; Karine Lolmède; Danièle Daviaud; Michel Berlan; Anne Bouloumié; Max Lafontan; Philippe Valet; Jean Sébastien Saulnier-Blache
Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(3):158-63.
2003: Fabrice Marion-Latard; François Crampes; Alexia Zakaroff-Girard; Isabelle De Glisezinski; Isabelle Harant; Vladimir Stich; Claire Thalamas; Daniel Rivière; Max Lafontan; Michel Berlan
Post-exercise increase of lipid oxidation after a moderate exercise bout in untrained healthy obese men.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(2):97-103.
2003: François Crampes; Fabrice Marion-Latard; Alexia Zakaroff-Girard; Isabelle De Glisezinski; Isabelle Harant; Claire Thalamas; Vladimir Stich; Daniel Rivière; Max Lafontan; Michel Berlan
Effects of a longitudinal training program on responses to exercise in overweight men.
Obesity research 2003;11(2):247-56.
2003: Michel Pelat; Patrick Verwaerde; Jean Galitzky; Max Lafontan; Michel Berlan; Jean-Michel Senard; Jean-Louis Montastruc
High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
The Journal of pharmacology and experimental therapeutics 2003;304(1):246-53.
2002: Hana Suljkovicova; Fabrice Marion-Latard; Jindra Hejnova; Marek Majercik; François Crampes; Isabelle De Glisezinski; Michel Berlan; Daniel Rivière; Vladimir Stich
Effect of macronutrient composition of the diet on the regulation of lipolysis in adipose tissue at rest and during exercise: microdialysis study.
Metabolism: clinical and experimental 2002;51(10):1291-7.
2002: Isabelle Harant; Fabrice Marion-Latard; François Crampes; Isabelle De Glisezinski; Michel Berlan; Vladimir Stich; Daniel Rivière
Effect of a long-duration physical exercise on fat cell lipolytic responsiveness to adrenergic agents and insulin in obese men.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(10):1373-8.
2002: Michel Berlan; Stephan Verhaeghe; Anne Pavy-Le Traon; Claire Thalamas; Max Lafontan; Marie-Adeline Marques; Jean-Michel Senard; Marc Parent; Jean Galitzky
Yohimbine administration prevents over-responsiveness to epinephrine induced by simulated microgravity.
Aviation, space, and environmental medicine 2002;73(8):735-42.
2002: Coralie Sengenes; Alexia Zakaroff-Girard; Agnès Moulin; Michel Berlan; Anne Bouloumié; Max Lafontan; Jean Galitzky
Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity.
American journal of physiology. Regulatory, integrative and comparative physiology 2002;283(1):R257-65.
2002: Max Lafontan; Michel Berlan; Vladimir Stich; François Crampes; Daniel Rivière; Isabelle De Glisezinski; Coralie Sengenes; Jean Galitzky
Recent data on the regulation of lipolysis by catecholamines and natriuretic peptides.
Annales d'endocrinologie 2002;63(2 Pt 1):86-90.
2002: Vladimir Stich; Fabrice Marion-Latard; Jindra Hejnova; Nathalie Viguerie; Corinne Lefort; Hana Suljkovicova; Dominique Langin; Max Lafontan; Michel Berlan
Hypocaloric diet reduces exercise-induced alpha 2-adrenergic antilipolytic effect and alpha 2-adrenergic receptor mRNA levels in adipose tissue of obese women.
The Journal of clinical endocrinology and metabolism 2002;87(3):1274-81.
2002: Coralie Sengenes; Vladimir Stich; Michel Berlan; Jindra Hejnova; Max Lafontan; Z Pariskova; Jean Galitzky
Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(1):24-32.
2001: Stephane Gesta; Jindra Hejnova; Michel Berlan; Danièle Daviaud; François Crampes; Vladimir Stich; Philippe Valet; Jean Sébastien Saulnier-Blache
In vitro and in vivo impairment of alpha2-adrenergic receptor-dependent antilipolysis by fatty acids in human adipose tissue.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2001;33(12):701-7.
2001: Isabelle De Glisezinski; Fabrice Marion-Latard; François Crampes; Michel Berlan; Jindra Hejnova; JM Cottet-Emard; Vladimir Stich; Daniel Rivière
Lack of alpha(2)-adrenergic antilipolytic effect during exercise in subcutaneous adipose tissue of trained men.
Journal of applied physiology (Bethesda, Md. : 1985) 2001;91(4):1760-5.
2001: Michel Pelat; Patrick Verwaerde; Marie-Antoinette Tran; Michel Berlan; Jean-Michel Senard; Jean-Louis Montastruc
Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatment.
Fundamental & clinical pharmacology 2001;15(4):239-45.
2001: Jean Galitzky; Coralie Sengenes; Claire Thalamas; Marie-Adeline Marques; J M Senard; Max Lafontan; Michel Berlan
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men.
Journal of lipid research 2001;42(4):536-44.
2001: Fabrice Marion-Latard; Isabelle De Glisezinski; François Crampes; Michel Berlan; Jean Galitzky; Hana Suljkovicova; Daniel Riviere; Vladimir Stich
A single bout of exercise induces beta-adrenergic desensitization in human adipose tissue.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(1):R166-73.
2000: Max Lafontan; Michel Berlan; Jean Galitzky
[Lipid mobilization and energy metabolism: impact of molecular and cellular approaches on the treatment of obesity].
Annales d'endocrinologie 2000;61 Suppl 6():56-69.
2000: Max Lafontan; Coralie Sengenes; Jean Galitzky; Michel Berlan; Isabelle De Glisezinski; François Crampes; Vladimir Stich; Dominique Langin; Pierre Barbe; Daniel Rivière
Recent developments on lipolysis regulation in humans and discovery of a new lipolytic pathway.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24 Suppl 4():S47-52.
2000: Vladimir Stich; Isabelle De Glisezinski; François Crampes; Jindra Hejnova; JM Cottet-Emard; Jean Galitzky; Max Lafontan; Daniel Rivière; Michel Berlan
Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects.
American journal of physiology. Regulatory, integrative and comparative physiology 2000;279(2):R499-504.
2000: Coralie Sengenes; Michel Berlan; Isabelle De Glisezinski; Max Lafontan; Jean Galitzky
Natriuretic peptides: a new lipolytic pathway in human adipocytes.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(10):1345-51.
2000: Claire Thalamas; Jean Galitzky; Jean-Michel Sénard; Max Lafontan; Jean-Louis Montastruc; Michel Berlan; Pierre Barbe
Glucose-induced sympathetic activity and energy expenditure during acute alpha2-adrenergic antagonism in obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(6):695-700.
2000: Vladimir Stich; Isabelle De Glisezinski; Michel Berlan; J Bulow; Jean Galitzky; Isabelle Harant; Hana Suljkovicova; Max Lafontan; Daniel Rivière; François Crampes
Adipose tissue lipolysis is increased during a repeated bout of aerobic exercise.
Journal of applied physiology (Bethesda, Md. : 1985) 2000;88(4):1277-83.
1999: Michel Pelat; Patrick Verwaerde; C Merial; Jean Galitzky; Michel Berlan; Jean-Louis Montastruc; Jean-Michel Senard
Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension.
Hypertension 1999;34(5):1066-72.
1999: Pierre Barbe; Jean Galitzky; Claire Thalamas; Dominique Langin; Max Lafontan; Jean-Michel Senard; Michel Berlan
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humans.
Journal of applied physiology (Bethesda, Md. : 1985) 1999;87(5):1614-20.
1999: Vladimir Stich; Isabelle De Glisezinski; François Crampes; Hana Suljkovicova; Jean Galitzky; Daniel Riviere; Jindra Hejnova; Max Lafontan; Michel Berlan
Activation of antilipolytic alpha(2)-adrenergic receptors by epinephrine during exercise in human adipose tissue.
The American journal of physiology 1999;277(4 Pt 2):R1076-83.
1999: Patrick Verwaerde; Jean-Michel Sénard; Michel Galinier; P Rougé; Pierre Massabuau; Jean Galitzky; Michel Berlan; Max Lafontan; Jean-Louis Montastruc
Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs.
Journal of hypertension 1999;17(8):1135-43.
1999: Christian Carpéné; Jean Galitzky; Emi Fontana; C Atgié; Max Lafontan; Michel Berlan
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(4):310-21.
1999: Vladimir Stich; Isabelle De Glisezinski; Jean Galitzky; Jindra Hejnova; François Crampes; Daniel Rivière; Michel Berlan
Endurance training increases the beta-adrenergic lipolytic response in subcutaneous adipose tissue in obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(4):374-81.
1999: A Bousquet-Mélou; C Muñoz; Jean Galitzky; Michel Berlan; Max Lafontan
Pregnancy modifies the alpha2-beta-adrenergic receptor functional balance in rabbit fat cells.
Journal of lipid research 1999;40(2):267-74.
1999: Jean-Louis Montastruc; Patrick Verwaerde; Michel Pelat; Jean Galitzky; Dominique Langin; Max Lafontan; Michel Berlan
Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
Fundamental & clinical pharmacology 1999;13(2):180-6.
1998: Isabelle De Glisezinski; François Crampes; Isabelle Harant; Michel Berlan; Jindra Hejnova; Dominique Langin; Daniel Rivière; Vladimir Stich
Endurance training changes in lipolytic responsiveness of obese adipose tissue.
The American journal of physiology 1998;275(6 Pt 1):E951-6.
1998: Michel Pelat; Patrick Verwaerde; E Lazartiques; P Cabrol; Jean Galitzky; Michel Berlan; Jean-Louis Montastruc; Jean-Michel Senard
[Twenty-four hour time and frequency domain variability of systolic blood pressure and heart rate in an experimental model of arterial hypertension plus obesity].
Archives des maladies du coeur et des vaisseaux 1998;91(8):999-1002.
1998: Pierre Barbe; Laurence Millet; Dominique Larrouy; Jean Galitzky; Michel Berlan; J P Louvet; Dominique Langin
Uncoupling protein-2 messenger ribonucleic acid expression during very-low-calorie diet in obese premenopausal women.
The Journal of clinical endocrinology and metabolism 1998;83(7):2450-3.
1998: Laurence Millet; Pierre Barbe; Max Lafontan; Michel Berlan; Jean Galitzky
Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue.
Journal of applied physiology (Bethesda, Md. : 1985) 1998;85(1):181-8.
1998: Christian Carpéné; A Bousquet-Mélou; Jean Galitzky; Michel Berlan; Max LAFONTAN
Lipolytic effects of beta 1-, beta 2-, and beta 3-adrenergic agonists in white adipose tissue of mammals.
Annals of the New York Academy of Sciences 1998;839():186-9.
1998: Pierre Barbe; Jean Galitzky; Isabelle De Glisezinski; Daniel Riviere; Claire Thalamas; Jean-Michel Senard; François Crampes; Max Lafontan; Michel Berlan
Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue.
The Journal of clinical endocrinology and metabolism 1998;83(2):619-25.
1998: Max Lafontan; S Betuing; Jean Sébastien Saulnier-Blache; Philippe Valet; Anne Bouloumié; Christian Carpéné; Jean Galitzky; Michel Berlan
Regulation of fat-cell function by alpha 2-adrenergic receptors.
Advances in pharmacology (San Diego, Calif.) 1998;42():496-8.
1997: Jean Galitzky; Dominique Langin; Patrick Verwaerde; Jean-Louis Montastruc; Max Lafontan; Michel Berlan
Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
British journal of pharmacology 1997;122(6):1244-50.
1997: Max Lafontan; Pierre Barbe; Jean Galitzky; Geneviève Tavernier; Dominique Langin; Christian Carpéné; A Bousquet-Melou; Michel Berlan
Adrenergic regulation of adipocyte metabolism.
Human reproduction (Oxford, England) 1997;12 Suppl 1():6-20.
1997: Patrick Verwaerde; Michel Galinier; Joelle Fourcade; Pierre Massabuau; Jean Galitzky; Jean-Michel Senard; Marie-Antoinette Tran; Michel Berlan; Jean-Louis Montastruc
[Autonomic nervous system abnormalities in the initial phase of insulin resistance syndrome. Value of the study of variability of cardiac rate and blood pressure on a model of nutritional obesity].
Archives des maladies du coeur et des vaisseaux 1997;90(8):1151-4.
1997: Pierre Massabuau; Patrick Verwaerde; Michel Galinier; Joelle Fourcade; P Rougé; Jean Galitzky; Jean-Michel Senard; Michel Berlan; Jean-Paul Bounhoure; Jean-Louis Montastruc
[Left ventricular repercussion of obesity-induced arterial hypertension in the dog].
Archives des maladies du coeur et des vaisseaux 1997;90(8):1033-5.
1997: Vladimir Stich; Isabelle Harant; Isabelle De Glisezinski; François Crampes; Michel Berlan; Marie Kunesova; Vojtech Hainer; M Dauzats; Daniel Rivière; M Garrigues; Cecilia Holm; Max Lafontan; Dominique Langin
Adipose tissue lipolysis and hormone-sensitive lipase expression during very-low-calorie diet in obese female identical twins.
The Journal of clinical endocrinology and metabolism 1997;82(3):739-44.
1997: Haleh Bagheri; Laurent Schmitt; Michel Berlan; Jean-Louis Montastruc
A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs.
European journal of clinical pharmacology 1997;52(5):339-42.
1997: Pierre Barbe; Vladimir Stich; Jean Galitzky; Marie Kunesova; Vojtech Hainer; Max Lafontan; Michel Berlan
In vivo increase in beta-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet.
The Journal of clinical endocrinology and metabolism 1997;82(1):63-9.
1996: Patrick Verwaerde; Michel Galinier; P Rougé; Pierre Massabuau; Jean Galitzky; Jean-Michel Sénard; Michel Berlan; Jean-Louis Montastruc
[Experimental hypertension induced by hypercaloric diet].
Archives des maladies du coeur et des vaisseaux 1996;89(8):1019-23.
1996: Pierre Barbe; Laurence Millet; Jean Galitzky; Max Lafontan; Michel Berlan
In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
British journal of pharmacology 1996;117(5):907-13.
1996: Geneviève Tavernier; Pierre Barbe; Jean Galitzky; Michel Berlan; D Caput; Max Lafontan; Dominique Langin
Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.
Journal of lipid research 1996;37(1):87-97.
1996: N Viguerie-Bascands; A Bousquet-Mélou; Jean Galitzky; Dominique Larrouy; Daniel Ricquier; Michel Berlan; Louis Casteilla
Evidence for numerous brown adipocytes lacking functional beta 3-adrenoceptors in fat pads from nonhuman primates.
The Journal of clinical endocrinology and metabolism 1996;81(1):368-75.
1995: Max Lafontan; Michel Berlan
Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis.
Endocrine reviews 1995;16(6):716-38.
1995: Max Lafontan; A Bousquet-Melou; Jean Galitzky; Pierre Barbe; Christian Carpéné; Dominique Langin; Michel Berlan; Philippe Valet; I Castan; A Bouloumié
Adrenergic receptors and fat cells: differential recruitment by physiological amines and homologous regulation.
Obesity research 1995;3 Suppl 4():507S-514S.
1995: A Bousquet-Mélou; Jean Galitzky; C M Moreno; Michel Berlan; Max Lafontan
Desensitization of beta-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesterase.
European journal of pharmacology 1995;289(2):235-47.
1995: A Bousquet-Mélou; Jean Galitzky; Max Lafontan; Michel Berlan
Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans.
Journal of lipid research 1995;36(3):451-61.
1995: Jean Galitzky; Christian Carpéné; A Bousquet-Mélou; Michel Berlan; Max Lafontan
Differential activation of beta 1-, beta 2- and beta 3-adrenoceptors by catecholamines in white and brown adipocytes.
Fundamental & clinical pharmacology 1995;9(4):324-31.
1995: Michel Berlan; Pierre Barbe; Vladimir Stich; Jean Galitzky; A Bousquet-Mélou; Max Lafontan
[Lipid mobilization, physiopathological and pharmacological aspects].
Annales d'endocrinologie 1995;56(2):97-100.
1995: Haleh Bagheri; J J Chale; L N Guyen; Marie-Antoinette Tran; Michel Berlan; Jean-Louis Montastruc
Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonist.
Fundamental & clinical pharmacology 1995;9(3):248-54.
1995: Michel Berlan; Jean Galitzky; Jean-Louis Montastruc
Beta 3-adrenoceptors in the cardiovascular system.
Fundamental & clinical pharmacology 1995;9(3):234-9.
1994: A Bousquet-Mélou; Jean Galitzky; Christian Carpéné; Max Lafontan; Michel Berlan
beta-Adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals.
The American journal of physiology 1994;267(1 Pt 2):R115-23.
1994: Michel Berlan; Jean Galitzky; A Bousquet-Melou; Max Lafontan; Jean-Louis Montastruc
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1444-51.
1994: Haleh Bagheri; Michel Berlan; Jean-Michel Senard; Olivier Rascol; Jean-Louis Montastruc
Lacrimation in Parkinson's disease.
Clinical neuropharmacology 1994;17(1):89-91.
1994: Haleh Bagheri; P Picault; Laurent Schmitt; G Houin; Michel Berlan; Jean-Louis Montastruc
Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.
British journal of clinical pharmacology 1994;37(1):93-6.
1993: Jean-Louis Montastruc; J Galitzky; Michel Berlan; P Montastruc
[Mechanism of receptor regulation during repeated administration of drugs].
Thérapie 1993;48(5):421-6.
1993: Pierre Barbe; Jean Galitzky; Daniel Riviere; Jean-Michel Senard; Max Lafontan; M Garrigues; Michel Berlan
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man.
British journal of clinical pharmacology 1993;36(1):25-30.
1993: Max Lafontan; Michel Berlan
Fat cell adrenergic receptors and the control of white and brown fat cell function.
Journal of lipid research 1993;34(7):1057-91.
1993: Jean Galitzky; M Reverte; C Carpene; Max Lafontan; Michel Berlan
Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
The Journal of pharmacology and experimental therapeutics 1993;266(1):358-66.
1993: Jean Galitzky; M Reverte; María P Portillo; Christian Carpéné; Max Lafontan; Michel Berlan
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
The American journal of physiology 1993;264(3 Pt 1):E403-12.
1993: Jean-Michel Senard; Olivier Rascol; G Durrieu; Marie-Antoinette Tran; Michel Berlan; A Rascol; Jean-Louis Montastruc
Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy.
Clinical neuropharmacology 1993;16(1):70-6.
1993: Jean Galitzky; C Carpene; Max Lafontan; Michel Berlan
[Specific stimulation of adipose tissue adrenergic beta 3 receptors by octopamine].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(5):519-23.
1992: Haleh Bagheri; Laurent Schmitt; Michel Berlan; Jean-Louis Montastruc
Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants.
British journal of clinical pharmacology 1992;34(6):555-8.
1992: Geneviève Tavernier; Jean Galitzky; A Bousquet-Melou; Jean-Louis Montastruc; Michel Berlan
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1083-90.
1992: M F Poncet; Christine Damase-Michel; G Tavernier; Marie-Antoinette Tran; Michel Berlan; Jean-Louis Montastruc; P Montastruc
Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.
British journal of pharmacology 1992;105(1):181-3.
1992: Max Lafontan; Michel Berlan; Jean Galitzky; Jean-Louis Montastruc
Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies.
The American journal of clinical nutrition 1992;55(1 Suppl):219S-227S.
1991: Jean Galitzky; M Vermorel; Max Lafontan; P Montastruc; Michel Berlan
Thermogenic and lipolytic effect of yohimbine in the dog.
British journal of pharmacology 1991;104(2):514-8.
1991: María P Portillo; M Reverte; Dominique Langin; Jean-Michel Senard; Marie-Antoinette Tran; Michel Berlan; Jean-Louis Montastruc
Effect of a 7-day treatment with idazoxan and its 2-methoxy derivative RX 821002 [correction of RX 821001] on alpha 2-adrenoceptors and non-adrenoceptor idazoxan binding sites in rabbits.
British journal of pharmacology 1991;104(1):190-4.
1991: M F Poncet; G Tavernier; Christine Damase-Michel; Marie-Antoinette Tran; Michel Berlan; Jean-Louis Montastruc; P Montastruc
[Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors].
Archives des maladies du coeur et des vaisseaux 1991;84(8):1239-41.
1991: Michel Berlan; Jean Galitzky; Daniel Riviere; M Foureau; Marie-Antoinette Tran; R Flores; J P Louvet; G Houin; Max Lafontan
Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.
International journal of obesity 1991;15(5):305-15.
1991: Jean-Michel Senard; G Durrieu; Michel Berlan; L Estan; Philippe Valet; Marie-Antoinette Tran; M Garrigues; Jean-Louis Montastruc
Absence of arterial hypertension despite chronic plasma noradrenaline elevation: evidence for down-regulation of alpha-adrenoceptors. A case report.
Fundamental & clinical pharmacology 1991;5(4):291-8.
1990: G Durrieu; Y Rispail; E Chatelut; Michel Berlan; A Rascol; Jean-Louis Montastruc; P Montastruc
Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
Clinical neuropharmacology 1990;13(6):492-9.
1990: Jean-Michel Senard; Philippe Valet; G Durrieu; Michel Berlan; Marie-Antoinette Tran; Jean-Louis Montastruc; A Rascol; P Montastruc
Adrenergic supersensitivity in parkinsonians with orthostatic hypotension.
European journal of clinical investigation 1990;20(6):613-9.
1990: L Estan; Jean-Michel Senard; Marie-Antoinette Tran; Jean-Louis Montastruc; Michel Berlan
Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog.
British journal of pharmacology 1990;101(2):329-36.
1990: Jean Galitzky; J M Senard; Max Lafontan; M Stillings; Jean-Louis Montastruc; Michel Berlan
Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
British journal of pharmacology 1990;100(4):862-6.
1990: Jean-Michel Senard; Pierre Barbe; L Estan; Rosine Guimbaud; J P Louvet; Michel Berlan; Marie-Antoinette Tran; Jean-Louis Montastruc
Decreased high affinity state in platelet alpha 2-adrenoceptors from diabetic patients with orthostatic hypotension.
The Journal of clinical endocrinology and metabolism 1990;71(2):311-7.
1990: G Durrieu; Philippe Valet; Michel Berlan; A Villeneuve; Jean-Louis Montastruc
Levodopa up-regulates platelet alpha 2-adrenoceptors.
European journal of pharmacology 1990;182(3):597-601.
1990: M Colomes; Y Rispail; Michel Berlan; J Pous; Jean-Louis Montastruc
[Drug consumption in a retired population].
Thérapie 1990;45(4):321-4.
1990: Pierre Barbe; Jean-Michel Senard; L Estan; Michel Berlan; Marie-Antoinette Tran; J P Louvet; Jean-Louis Montastruc
[Platelet alpha 2 adrenergic receptors, plasma catecholamines and orthostatic hypotension in insulin-dependent diabetic patients].
Archives des maladies du coeur et des vaisseaux 1990;83(8):1245-8.
1990: Philippe Valet; Michel Berlan; M Beauville; François Crampes; Jean-Louis Montastruc; Max Lafontan
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
The Journal of clinical investigation 1990;85(1):291-5.
1990: Y Rispail; L Schmitt; Michel Berlan; Jean-Louis Montastruc; P Montastruc
Yohimbine increases salivary secretion in depressed patients treated with tricyclic antidepressants.
European journal of clinical pharmacology 1990;39(4):425-6.
1990: Jean Galitzky; Dominique Larrouy; Michel Berlan; Max Lafontan
New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
The Journal of pharmacology and experimental therapeutics 1990;252(1):312-9.
1990: Jean Galitzky; Daniel Rivière; Marie-Antoinette Tran; Jean-Louis Montastruc; Michel Berlan
Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.
European journal of clinical pharmacology 1990;39(5):447-51.
1989: Jean Sébastien Saulnier-Blache; M Taouis; M Dauzats; A Uzan; Michel Berlan; Max Lafontan
Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
The Journal of pharmacology and experimental therapeutics 1989;251(3):1187-92.
1989: Jean Sébastien Saulnier-Blache; M Taouis; M Dauzats; A Uzan; Michel Berlan; Max Lafontan
Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
The Journal of pharmacology and experimental therapeutics 1989;251(3):1193-8.
1989: P Montastruc; Michel Berlan; Jean-Louis Montastruc
Effects of yohimbine on submaxillary salivation in dogs.
British journal of pharmacology 1989;98(1):101-4.
1989: E Chatelut; Y Rispail; Michel Berlan; Jean-Louis Montastruc
Yohimbine increases human salivary secretion.
British journal of clinical pharmacology 1989;28(3):366-8.
1989: M Taosis; Philippe Valet; L Estan; Max LAFONTAN; P Montastruc; Michel Berlan
Obesity modifies the adrenergic status of dog adipose tissue.
The Journal of pharmacology and experimental therapeutics 1989;250(3):1061-6.
1989: Jean Galitzky; Max Lafontan; Hervé Paris; Michel Berlan
Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
The Journal of pharmacology and experimental therapeutics 1989;249(2):592-600.
1989: Jean Galitzky; P Mauriege; Michel Berlan; Max Lafontan
Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
The Journal of pharmacology and experimental therapeutics 1989;249(2):583-91.
1989: Philippe Valet; M Taouis; Marie-Antoinette Tran; P Montastruc; Max Lafontan; Michel Berlan
Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects.
British journal of pharmacology 1989;97(1):229-39.
1989: Michel Berlan; Olivier Rascol; J Belin; J P Moatti; A Rascol; Jean-Louis Montastruc
Alpha 2-adrenergic sensitivity in Parkinson's disease.
Clinical neuropharmacology 1989;12(2):138-44.
1989: Philippe Valet; Jean-Louis Montastruc; Michel Berlan; M A Tran; Max Lafontan; P Montastruc
Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog.
The Journal of pharmacology and experimental therapeutics 1989;249(1):271-7.
1989: François Crampes; M Marceron; M Beauville; Daniel Riviere; M Garrigues; Michel Berlan; Max Lafontan
Platelet alpha 2-adrenoceptors and adrenergic adipose tissue responsiveness after moderate hypocaloric diet in obese subjects.
International journal of obesity 1989;13(1):99-110.
1988: Jean Galitzky; M Taouis; Michel Berlan; Daniel Rivière; M Garrigues; Max Lafontan
Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers.
European journal of clinical investigation 1988;18(6):587-94.
1988: M Taouis; Michel Berlan; P Montastruc; Max Lafontan
Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog.
The Journal of pharmacology and experimental therapeutics 1988;247(3):1172-80.
1988: P Mauriège; G De Pergola; Michel Berlan; Max Lafontan
Human fat cell beta-adrenergic receptors: beta-agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta 1-antagonists.
Journal of lipid research 1988;29(5):587-601.
1988: Max Lafontan; Michel Berlan; M Prud'Hon
[Beta adrenergic agonists. Mechanisms of action: lipid mobilization and anabolism].
Reproduction, nutrition, development 1988;28(1):61-84.
1987: M Taouis; Michel Berlan; P Montastruc; Max Lafontan
Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.
The Journal of pharmacology and experimental therapeutics 1987;242(3):1041-9.